Activist investor Jana Partners built a new stake in QuidelOrtho during the first quarter, though it is unclear whether the hedge fund will seek changes at the U.S. diagnostics company, sources familiar with the hedge fund’s position told Reuters’ Svea Herbst-Bayliss. QuidelOrtho shares are up $2.17, or 5%, to $44.28 following Reuters’ report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: